Navigation Links
Improving Life Expectancy

Researchers from several international centers combined efforts to determine the potential health gains of reducing risk factors for disease. They looked at 20 risk factors.// Some of those include unsafe sex, alcohol use, unsafe water, sanitation and hygiene, indoor smoke, childhood sexual abuse, and vitamin deficiencies.

They found 47 percent of premature deaths and 39 percent of total diseases around the world in 2000 resulted from a combination of risk factors. Some of the health problems that resulted were diarrhea, lower respiratory infections, lung cancer, chronic obstructive pulmonary disease, heart disease and stroke. Researchers say removing the risks would increase life expectancy by an average of nine years, depending on the location, “The analysis showed that even populations with high life expectancy at present, such as developed regions of the western Pacific and western Europe, could benefit considerably from risk reduction.”

Study investigators believe this information can lead people to make improvements in their health. They say, “The implementation of affordable and effective prevention strategy should incorporate the interaction of major risks to health.”
'"/>




Page: 1

Related medicine news :

1. Plastic Sling Has Proved Successful In Improving Aging Of The Neck
2. Improving Survival Rate Of Lung Cancer Patients
3. Combination Therapy Effective In Improving Lung Cancer Survival
4. Improving Fertility In Patients With Cervical Cancer
5. Improving The Survival Of Lung Cancer Patients By Blocking The Effects Of Estrogen
6. Improving Lighting Could Bring About A Change In Alzheimers Patients
7. Device For Improving Bone Mass In Osteoporosis
8. Olive Oil Found To Preserve Cardiovascular Health by Improving Function
9. US To Look In To Improving the Elder Care
10. Saw Palmetto Extract No Good In Improving Prostate Health
11. Rahul Mahajans Condition Improving; Vital Parametres Normal
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Improving Life Expectancy

(Date:5/15/2008)...al of tailoring cancer treatment for each individu...enter today presented a study suggesting a simple ...reatment efficacy for patients with metastatic bre...times months to determine if a particular cancer t...to observe any significant radiographic changes in...
(Date:5/15/2008)...Newswire-FirstCall/ -- Digital Power,Corporation (...ced its,financial results for the first quarter en...ue of $3,169,000 for the quarter ended,March 31, 2...same quarter,last year. An operating loss of $165,...mpared to an operating profit of $25,000 for the s...
(Date:5/15/2008)...15 /PRNewswire-FirstCall/ -- Alexza,Pharmaceutical...os A. Parra,has joined the company as Vice Preside...development and execution of quality program,strat...eclinical / clinical,product candidates. Mr. Parra...Quality at Telik, Inc. in Palo Alto, California, w...
(Date:5/15/2008)...15 /PRNewswire/ -- Congresswoman Lois Capps,(D-CA)...mmittee organized a,briefing for key staff members...n to ban asbestos., WHEN: Monday, May 19th at 2...218 List of discussants includes Mary Hesdorffer,...the Mesothelioma Applied Research Foundation, who,...
Breaking Medicine News(10 mins):Health News:Study suggests blood test can help improve treatment outcomes for breast cancer patients 2Health News:Digital Power Reports Financial Results for the First Quarter Ended March 31, 2008 2Health News:Digital Power Reports Financial Results for the First Quarter Ended March 31, 2008 3Health News:Carlos A. Parra Joins Alexza Pharmaceuticals as Vice President, Quality 2
..., which can be likened to about two to four drinks...ay actually be a way to live// longer. While moder... risk of death, Italian researchers have said. Re... should be urged to cut their consumption, but peo...
...trial chemicals in the environment can damage the ...l disorders (NDDs)—autism,// attention deficit dis... has been insufficient research done to identify t...e injury to the developing brains of children. In...
Testosterone Decline in Men Linked to Lifestyle, Increases in Obese Girls
...e of the toughest and most strenuous jobs. A Canad...that the workload// and strain makes them sick. T... 2006 on nearly 19,000 nurses, which included regi...ctical nurses and registered psychiatric nurses. ...
Other Medicine News:Health News:Industrial Chemicals Are Impairing the Brain Development of Children Worldwide 2Health News:Industrial Chemicals Are Impairing the Brain Development of Children Worldwide 3Health News:Industrial Chemicals Are Impairing the Brain Development of Children Worldwide 4Health News:Testosterone Decline in Men Linked to Lifestyle, Increases in Obese Girls 2
(Date:5/14/2008)...r cervical cancer prevention, GRAZ, Austria, May ...nded follow-up study show that GlaxoSmithKline (NY...ARIX(R) generates sustained high levels of,neutral...cal cancer-causing,human papillomavirus types for ...ustained neutralizing antibody levels observed aga...
(Date:5/14/2008)...-- Results of the PRoFESS(R),(Prevention Regimen F...he,world,s largest clinical research study for sec...t the XVII European Stroke Conference in Nice,Fra...r Aggrenox(R) and,clopidogrel were similar (9.0% a... The study did not meet its primary endpoint of no...
(Date:5/14/2008)...ate to lead expansion of Cytel,s adaptiv...IDGE, Mass., May 14 /- Cytel Inc., a ... and specialized statistical software,today annou...sident,Adaptive Trials., Judith Quinlan brings o...Cytel team. Prior to joining Cytel Judith spent 10...
(Date:5/14/2008)...stCall/ -- Kosan Biosciences,Incorporated (Nasdaq:...,presented on tanespimycin, the company,s lead Hsp...with Herceptin(R) in patients with HER2-positive,m...g of the American,Society of Clinical Oncology (AS...ay 31 through June 3, 2008., Abstract 1027, title...
Breaking Medicine Technology:CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date 2CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date 3CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date 4CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date 5CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date 6PRoFESS(R) Results Announced at XVII European Stroke Conference 2PRoFESS(R) Results Announced at XVII European Stroke Conference 3PRoFESS(R) Results Announced at XVII European Stroke Conference 4PRoFESS(R) Results Announced at XVII European Stroke Conference 5Judith Quinlan Joins Cytel as Vice President, Adaptive Trials 2Kosan Announces Data Presentations at ASCO 2008 Annual Meeting 2Kosan Announces Data Presentations at ASCO 2008 Annual Meeting 3Cell Therapeutics Inc 28CTI 29 to Report Fourth Quarter and Year End Financial Results on March 13 3782 1Genetic manipulation might model cystic fibrosis 3780 1Researchers engineer new polymers to change their stiffness and strength when exposed to liquids 3778 1Researchers engineer new polymers to change their stiffness and strength when exposed to liquids 3778 2Researchers engineer new polymers to change their stiffness and strength when exposed to liquids 3778 3Nfocus Neuromedical Announces Acquisition of StarFire Medical 13747 1Nfocus Neuromedical Announces Acquisition of StarFire Medical 13747 2
...7 - Professor Ian,Meredith, M.D., Monash Medical C...positive nine-month results from the Medtronic,RES...celona, Spain,with data showing a low number of a...t thrombosis. The next-generation Medtronic,(NYSE:...m with new,BioLinx(TM) polymer is designed to addr...
...horoidal,Neovascularization (CNV) in an AMD Model,... Lpath, Inc. ,the category leader in therapeutic ...ng proof-of-concept data in a standard animal,mode... , The results were presented at the annual meetin...thalmology (ARVO) by Glenn,L. Stoller, M.D., head ...
Other Medicine Technology:Medtronic Announces Positive Nine-Month Results for Endeavor,Resolute Next Generation Drug-Eluting Stent at EuroPCR 2Medtronic Announces Positive Nine-Month Results for Endeavor,Resolute Next Generation Drug-Eluting Stent at EuroPCR 3Lpath Demonstrates 'First-in-Class' AMD Results With Its Lead Drug,Candidate, Sphingomab 2Lpath Demonstrates 'First-in-Class' AMD Results With Its Lead Drug,Candidate, Sphingomab 3Lpath Demonstrates 'First-in-Class' AMD Results With Its Lead Drug,Candidate, Sphingomab 4
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: